BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu M, Wu J, Hao ZW, Shang YK, Xu J, Nan G, Li X, Chen ZN, Bian H. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress. Hepatology 2018;68:317-32. [PMID: 29356040 DOI: 10.1002/hep.29798] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Zhang X, Zhou J, Li W, Shu X, Wu Y, Long M. Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer. Adv Drug Deliv Rev 2022;188:114448. [PMID: 35820602 DOI: 10.1016/j.addr.2022.114448] [Reference Citation Analysis]
2 Pourhamzeh M, Asadian S, Mirzaei H, Minaei A, Shahriari E, Shpichka A, Es HA, Timashev P, Hassan M, Vosough M. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma. Mol Cell Biochem 2022. [PMID: 35708866 DOI: 10.1007/s11010-022-04483-4] [Reference Citation Analysis]
3 Zhang K, Lin L, Zhu Y, Zhang N, Zhou M, Li Y. Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway. Front Pharmacol 2022;13:894981. [DOI: 10.3389/fphar.2022.894981] [Reference Citation Analysis]
4 Gorący A, Rosik J, Szostak B, Ustianowski Ł, Ustianowska K, Gorący J. Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview. Viruses 2022;14:1092. [DOI: 10.3390/v14051092] [Reference Citation Analysis]
5 Rahat MA. Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence? Front Immunol 2022;13:855978. [PMID: 35418981 DOI: 10.3389/fimmu.2022.855978] [Reference Citation Analysis]
6 Gu Z, Du Y, Zhao X, Wang C. Diagnostic, Therapeutic, and Prognostic Value of the m6A Writer Complex in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:822011. [PMID: 35223847 DOI: 10.3389/fcell.2022.822011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ghasemi K, Ghasemi K. A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies. Eur J Pharmacol 2022;916:174593. [PMID: 34973952 DOI: 10.1016/j.ejphar.2021.174593] [Reference Citation Analysis]
8 Behl T, Kaur I, Aleya L, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target. Sci Total Environ 2021;808:152072. [PMID: 34863742 DOI: 10.1016/j.scitotenv.2021.152072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tocan V, Hayase J, Kamakura S, Kohda A, Ohga S, Kohjima M, Sumimoto H. Hepatocyte polarity establishment and apical lumen formation are organized by Par3, Cdc42, and aPKC in conjunction with Lgl. J Biol Chem 2021;297:101354. [PMID: 34717957 DOI: 10.1016/j.jbc.2021.101354] [Reference Citation Analysis]
10 Fan C, Kam S, Ramadori P. Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer. Cancers (Basel) 2021;13:5250. [PMID: 34680398 DOI: 10.3390/cancers13205250] [Reference Citation Analysis]
11 Zhang Q, Liu F, Qin L, Liao Z, Song J, Liang H, Chen X, Zhang Z, Zhang B. Characterization of TGFβ-associated molecular features and drug responses in gastrointestinal adenocarcinoma. BMC Gastroenterol 2021;21:284. [PMID: 34247571 DOI: 10.1186/s12876-021-01869-4] [Reference Citation Analysis]
12 Wang S, Ma L, Wang Z, He H, Chen H, Duan Z, Li Y, Si Q, Chuang TH, Chen C, Luo Y. Lactate Dehydrogenase-A (LDH-A) Preserves Cancer Stemness and Recruitment of Tumor-Associated Macrophages to Promote Breast Cancer Progression. Front Oncol 2021;11:654452. [PMID: 34178639 DOI: 10.3389/fonc.2021.654452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kang Q, Tong Y, Gowd V, Wang M, Chen F, Cheng KW. Oral administration of EGCG solution equivalent to daily achievable dosages of regular tea drinkers effectively suppresses miR483-3p induced metastasis of hepatocellular carcinoma cells in mice. Food Funct 2021;12:3381-92. [PMID: 33900350 DOI: 10.1039/d1fo00664a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lu H, Zhu L, Li W, Hu S, Ge Y, Liu D. Novel gene-encoded intermolecular FRET sensor for tracking glycosylation of CD147 in living cells. Anal Bioanal Chem 2021;413:3193-9. [PMID: 33755768 DOI: 10.1007/s00216-021-03256-0] [Reference Citation Analysis]
15 Qian JY, Wang B, Lv LL, Liu BC. Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019. Front Physiol 2021;12:586589. [PMID: 33679428 DOI: 10.3389/fphys.2021.586589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lv JJ, Wang H, Cui HY, Liu ZK, Zhang RY, Lu M, Li C, Yong YL, Liu M, Zhang H, Zhang TJ, Zhang K, Li G, Nan G, Zhang C, Guo SP, Wang L, Chen ZN, Bian H. Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis. Front Cell Dev Biol 2020;8:609090. [PMID: 33490072 DOI: 10.3389/fcell.2020.609090] [Reference Citation Analysis]
17 Cao Y, Zhang H. Recent advances in nano material-based application of liver neoplasms. Smart Materials in Medicine 2021;2:114-23. [DOI: 10.1016/j.smaim.2021.03.001] [Reference Citation Analysis]
18 Hou J, Yan D, Liu Y, Huang P, Cui H. The Roles of Integrin α5β1 in Human Cancer. Onco Targets Ther 2020;13:13329-44. [PMID: 33408483 DOI: 10.2147/OTT.S273803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zarubin A, Stepanov V, Markov A, Kolesnikov N, Marusin A, Khitrinskaya I, Swarovskaya M, Litvinov S, Ekomasova N, Dzhaubermezov M, Maksimova N, Sukhomyasova A, Shtygasheva O, Khusnutdinova E, Radzhabov M, Kharkov V. Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy. Genes (Basel) 2020;12:E19. [PMID: 33375616 DOI: 10.3390/genes12010019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, Wei D, Zhang Y, Sun XX, Gong L, Yang X, He L, Zhang L, Yang Z, Geng JJ, Chen R, Zhang H, Wang B, Zhu YM, Nan G, Jiang JL, Li L, Wu J, Lin P, Huang W, Xie L, Zheng ZH, Zhang K, Miao JL, Cui HY, Huang M, Zhang J, Fu L, Yang XM, Zhao Z, Sun S, Gu H, Wang Z, Wang CF, Lu Y, Liu YY, Wang QY, Bian H, Zhu P, Chen ZN. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 2020;5:283. [PMID: 33277466 DOI: 10.1038/s41392-020-00426-x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 190] [Article Influence: 68.5] [Reference Citation Analysis]
21 Min A, Xiong H, Wang W, Hu X, Wang C, Mao T, Yang L, Huang D, Xia K, Su T. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin. J Oral Pathol Med 2020;49:1019-29. [PMID: 32740991 DOI: 10.1111/jop.13088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
22 Zhang T, Li H, Wang K, Xu B, Chen ZN, Bian H. Deficiency of CD147 Attenuated Non-alcoholic Steatohepatitis Progression in an NLRP3-Dependent Manner. Front Cell Dev Biol 2020;8:784. [PMID: 32903542 DOI: 10.3389/fcell.2020.00784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Wang SJ, Chao D, Wei W, Nan G, Li JY, Liu FL, Li L, Jiang JL, Cui HY, Chen ZN. CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma. J Exp Clin Cancer Res 2020;39:145. [PMID: 32727598 DOI: 10.1186/s13046-020-01647-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zhou H, Fang Y, Xu T, Ni WJ, Shen AZ, Meng XM. Potential therapeutic targets and promising drugs for combating SARS-CoV-2. Br J Pharmacol 2020;177:3147-61. [PMID: 32368792 DOI: 10.1111/bph.15092] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 16.5] [Reference Citation Analysis]
25 Rusu AD, Georgiou M. The multifarious regulation of the apical junctional complex. Open Biol 2020;10:190278. [PMID: 32070233 DOI: 10.1098/rsob.190278] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
26 Wu Y, Feng W, Liu R, Xia T, Liu S. Graphene Oxide Causes Disordered Zonation Due to Differential Intralobular Localization in the Liver. ACS Nano 2020;14:877-90. [PMID: 31891481 DOI: 10.1021/acsnano.9b08127] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
27 Chen R, Wang K, Feng Z, Zhang MY, Wu J, Geng JJ, Chen ZN. CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ. Cell Mol Immunol 2021;18:171-81. [PMID: 31900457 DOI: 10.1038/s41423-019-0353-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Fujii T, Duarte S, Lee E, Ke B, Busuttil RW, Coito AJ. Tissue Inhibitor of Metalloproteinase 3 Deficiency Disrupts the Hepatocyte E-Cadherin/β-Catenin Complex and Induces Cell Death in Liver Ischemia/Reperfusion Injury. Liver Transpl 2020;26:113-26. [PMID: 31642174 DOI: 10.1002/lt.25667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Qi S, Su L, Li J, Zhang C, Ma Z, Liu G, Zhang Q, Jia G, Piao Y, Zhang S. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes. J Exp Clin Cancer Res 2019;38:471. [PMID: 31752956 DOI: 10.1186/s13046-019-1464-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhang RY, Wei D, Liu ZK, Yong YL, Wei W, Zhang ZY, Lv JJ, Zhang Z, Chen ZN, Bian H. Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy. Front Cell Dev Biol 2019;7:233. [PMID: 31681766 DOI: 10.3389/fcell.2019.00233] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
31 Wang S, Li M, Xing L, Yu J. High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma. Oncol Lett 2019;18:4691-702. [PMID: 31611978 DOI: 10.3892/ol.2019.10846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Yong Y, Zhang R, Liu Z, Wei D, Shang Y, Wu J, Zhang Z, Li C, Chen Z, Bian H. Gamma‐secretase complex‐dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma. J Pathol 2019;249:255-67. [DOI: 10.1002/path.5316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
33 Hui L, Zhang S, Wudu M, Ren H, Xu Y, Zhang Q, Qiu X. CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion. Thorac Cancer 2019;10:1479-88. [PMID: 31124298 DOI: 10.1111/1759-7714.13097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
34 Kumar D, Vetrivel U, Parameswaran S, Subramanian KK. Structural insights on druggable hotspots in CD147: A bull's eye view. Life Sciences 2019;224:76-87. [DOI: 10.1016/j.lfs.2019.03.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
35 Yoshioka T, Kosugi T, Masuda T, Watanabe T, Ryuge A, Nagaya H, Maeda K, Sato Y, Katsuno T, Kato N, Ishimoto T, Yuzawa Y, Maruyama S, Kadomatsu K. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling. Am J Pathol 2019;189:1338-50. [PMID: 31014956 DOI: 10.1016/j.ajpath.2019.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Meng J, Gu F, Fang H, Qu B. Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection. J Cancer 2019;10:408-15. [PMID: 30719134 DOI: 10.7150/jca.28409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Yu B, Zhang Y, Wu K, Wang L, Jiang Y, Chen W, Yan M. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling. J Cell Mol Med 2019;23:954-66. [PMID: 30421493 DOI: 10.1111/jcmm.13996] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
38 Liu M, Jiang K, Lin G, Liu P, Yan Y, Ye T, Yao G, Barr MP, Liang D, Wang Y, Gong P, Meng S, Piao H. Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation. J Exp Clin Cancer Res 2018;37:165. [PMID: 30041665 DOI: 10.1186/s13046-018-0806-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
39 [DOI: 10.1101/2020.03.14.988345] [Cited by in Crossref: 271] [Cited by in F6Publishing: 48] [Reference Citation Analysis]